Mitochondrial Involvement in Migration, Invasion and Metastasis

Tatiana V. Denisenko; Anna S. Gorbunova; Boris Zhivotovsky

doi:10.3389/fcell.2019.00355

journal article Open Access Dec 20, 2019

Mitochondrial Involvement in Migration, Invasion and Metastasis

Tatiana V. Denisenko Anna S. Gorbunova Boris Zhivotovsky

Frontiers in Cell and Developmental Biology Vol. 7 · Frontiers Media SA

View at Publisher Save 10.3389/fcell.2019.00355

Topics

No keywords indexed for this article. Browse by subject →

References

188

[1]

The BCL-2 arbiters of apoptosis and their growing role as cancer targets

Jerry M Adams, Suzanne Cory

Cell Death & Differentiation 2018 10.1038/cdd.2017.161

[2]

Ahmad "Phosphoglucose Isomerase/Autocrine Motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells." Cancer Res. (2011) 10.1158/0008-5472.can-10-0965

[3]

Báthori "Ca2+ -dependent control of the permeability properties of the mitochondrial outer membrane and voltage-dependent anion-selective channel (VDAC)." J. Biol. Chem. (2006) 10.1074/jbc.m600906200

[4]

Beckner "Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis." Lab. Invest. (2005) 10.1038/labinvest.3700355

[5]

Ben-Kasus Nissim "Mitochondria control store-operated Ca2+ entry through Na + and redox signals." EMBO J. (2017) 10.15252/embj.201592481

[6]

Besbes "New dimension in therapeutic targeting of BCL-2 family proteins." Oncotarget (2015) 10.18632/oncotarget.3868

[7]

Billard "BH3 mimetics: status of the field and new developments." Mol. Cancer Ther. (2013) 10.1158/1535-7163.mct-13-0058

[8]

Bittremieux "Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2." Cell Death Differ. (2019) 10.1038/s41418-018-0142-3

[9]

Boisvert-Adamo "Mcl-1 is required for melanoma cell resistance to anoikis." Mol. Cancer Res. (2009) 10.1158/1541-7786.mcr-08-0358

[10]

Bower "SERCA directs cell migration and branching across species and germ layers." Biol. Open (2017) 10.1242/bio.026039

[11]

Caino "Molecular pathways: mitochondrial reprogramming in tumor progression and therapy." Clin. Cancer Res. (2016) 10.1158/1078-0432.ccr-15-0460

[12]

Caino "Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells." J. Clin. Invest. (2013) 10.1172/jci67841

[13]

Caino "A neuronal network of mitochondrial dynamics regulates metastasis." Nat. Commun. (2016) 10.1038/ncomms13730

[14]

ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development

Shundong Cang, Chaitanya Iragavarapu, John Savooji et al.

Journal of Hematology & Oncology 2015 10.1186/s13045-015-0224-3

[15]

Cannito "Epithelial–mesenchymal transition: from molecular mechanisms. Redox regulation to implications in human health and disease." Antioxid. Redox Signal. (2010) 10.1089/ars.2009.2737

[16]

Cekanova "BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasion." Exp. Cell Res (2015) 10.1016/j.yexcr.2014.11.016

[17]

Cervantes-Madrid "Reviving lonidamine and 6-Diazo-5-oxo-L-norleucine to be used in combination for metabolic cancer therapy." Biomed. Res. Int. (2015) 10.1155/2015/690492

[18]

A Perspective on Cancer Cell Metastasis

Christine L. Chaffer, Robert A. Weinberg

Science 2011 10.1126/science.1203543

[19]

Cheng "Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis." Nat. Commun. (2019) 10.1038/s41467-019-10042-1

[20]

Cheong "Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models." Mol. Cancer Ther. (2011) 10.1158/1535-7163.mct-11-0497

[21]

Chi "Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway." Cell Death Dis. (2016) 10.1038/cddis.2016.227

[22]

Chiu "Bcl-2 regulates store-operated Ca2+ entry to modulate ER stress-induced apoptosis." Cell Death Discov. (2018) 10.1038/s41420-018-0039-4

[23]

Chourasia "Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis." EMBO Rep. (2015) 10.15252/embr.201540759

[24]

Comito "HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells." Free Radic. Biol. Med. (2011) 10.1016/j.freeradbiomed.2011.05.042

[25]

Corcoran "Redox regulation of protein kinases." FEBS J. (2013) 10.1111/febs.12224

[26]

Costello "Why do tumour cells glycolyse?”: from glycolysis through citrate to lipogenesis." Mol. Cell. Biochem. (2005) 10.1007/s11010-005-8841-8

[27]

Coutinho-Camillo "Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma." Histopathology (2010) 10.1111/j.1365-2559.2010.03621.x

[28]

Cuevas "LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway." Sci. Rep. (2017) 10.1038/srep44988

[29]

da Veiga Moreira "Metabolic therapies inhibit tumor growth in vivo and in silico." Sci. Rep. (2019) 10.1038/s41598-019-39109-1

[30]

De Luise "Molecular and metabolic features of oncocytomas: seeking the blueprints of indolent cancers." Biochim. Biophys. Acta Bioenerg. (2017) 10.1016/j.bbabio.2017.01.009

[31]

De Pinto "Transmembrane arrangement of mitochondrial porin or voltage-dependent anion channel (VDAC)." J. Bioenerg. Biomembr. (1992) 10.1007/bf00769526

[32]

Fundamentals of cancer metabolism

Ralph J. DeBerardinis, Navdeep S. Chandel

Science Advances 2016 10.1126/sciadv.1600200

[33]

D’Ignazio "Hypoxia and inflammation in cancer, focus on HIF and NF-κB." Biomedicines (2017) 10.3390/biomedicines5020021

[34]

DiNardo "Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study." Lancet Oncol. (2018) 10.1016/s1470-2045(18)30010-x

[35]

Dong "Loss of FBP1 by snail-mediated repression provides metabolic advantages in basal-like breast cancer." Cancer Cell (2013) 10.1016/j.ccr.2013.01.022

[36]

Duan "Hypoxia induced Bcl-2/Twist1 complex promotes tumor cell invasion in oral squamous cell carcinoma." Oncotarget (2017) 10.18632/oncotarget.13890

[37]

Dupuy "PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer." Cell Metab. (2015) 10.1016/j.cmet.2015.08.007

[38]

Eckenrode "Apoptosis protection by Mcl-1 and Bcl-2 modulation of inositol 1,4,5-trisphosphate receptor-dependent Ca2+ signaling." J. Biol. Chem. (2010) 10.1074/jbc.m109.096040

[39]

Elia "Organ-specific cancer metabolism and its potential for therapy." Hand. Exp. Pharmacol. (2015) 10.1007/164_2015_10

[40]

Favre "Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells." Oncogene (2010) 10.1038/onc.2010.146

[41]

Feng "Epithelial-to-mesenchymal transition activates PERK-eIF2 and sensitizes cells to endoplasmic reticulum stress." Cancer Discov. (2014) 10.1158/2159-8290.cd-13-0945

[42]

Fouqué "The apoptotic members CD95. BclxL and Bcl-2 cooperate to promote cell migration by inducing Ca2+ flux from the endoplasmic reticulum to mitochondria." Cell Death Differ. (2016) 10.1038/cdd.2016.61

[43]

Reactive oxygen species and cancer paradox: To promote or to suppress?

Sehamuddin Galadari, Anees Rahman, Siraj Pallichankandy et al.

Free Radical Biology and Medicine 2017 10.1016/j.freeradbiomed.2017.01.004

[44]

Geng "Correlation between chemosensitivity to anticancer drugs and Bcl-2 expression in gastric cancer." Int. J. Clin. Exp. Pathol. (2013)

[45]

Ghosh "adaptive mitochondrial reprogramming and resistance to PI3K therapy." JNCI J. Natl. Cancer Inst. (2015) 10.1093/jnci/dju502

[46]

Gogvadze "Mitochondria in cancer cells: what is so special about them?" Trends Cell Biol. (2008) 10.1016/j.tcb.2008.01.006

[47]

Gorrini "Modulation of oxidative stress as an anticancer strategy." Nat. Rev. Drug Discov. (2013) 10.1038/nrd4002

[48]

Griguer "Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines." J. Neurooncol. (2005) 10.1007/s11060-004-6404-6

[49]

Gueguinou "The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis." Oncogene (2017) 10.1038/onc.2016.501

[50]

Guha "Mitochondrial retrograde signaling induces epithelial–mesenchymal transition and generates breast cancer stem cells." Oncogene (2014) 10.1038/onc.2013.467

Showing 50 of 188 references

Metrics

118

Citations

188

References

Details

Published: Dec 20, 2019
Vol/Issue: 7
License: View

Authors

Funding

Russian Science Foundation

Cancerfonden

Russian Foundation for Fundamental Investigations Award: 19-015-00332

Radiumhemmets Forskningsfonder

Cite This Article

Tatiana V. Denisenko, Anna S. Gorbunova, Boris Zhivotovsky (2019). Mitochondrial Involvement in Migration, Invasion and Metastasis. Frontiers in Cell and Developmental Biology, 7. https://doi.org/10.3389/fcell.2019.00355

Mitochondrial Involvement in Migration, Invasion and Metastasis

You May Also Like